SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001493152-21-001200
Filing Date
2021-01-15
Accepted
2021-01-15 17:24:52
Documents
23

Document Format Files

Seq Description Document Type Size
1 forms-4.htm S-4 8895634
2 ex21-1.htm EX-21.1 7076
3 ex23-3.htm EX-23.3 4513
4 ex23-4.htm EX-23.4 3610
5 ex23-5.htm EX-23.5 3658
6 ex99-3.htm EX-99.3 6188
7 image_001.jpg GRAPHIC 3518
8 image_002.jpg GRAPHIC 3058
9 image_003.jpg GRAPHIC 3772
10 image_004.jpg GRAPHIC 5516
11 pg201-250_001.jpg GRAPHIC 32604
12 pg201-250_002.jpg GRAPHIC 44022
13 pg201-250_003.jpg GRAPHIC 21502
14 pg201-250_004.jpg GRAPHIC 45782
15 pg201-250_005.jpg GRAPHIC 21410
16 pg201-250_006.jpg GRAPHIC 18932
17 pg201-250_007.jpg GRAPHIC 26920
18 pg201-250_008.jpg GRAPHIC 8333
19 pg201-250_009.jpg GRAPHIC 14233
20 pg201-250_010.jpg GRAPHIC 9832
21 annexf_001.jpg GRAPHIC 243732
22 annexf_002.jpg GRAPHIC 178345
23 ex99-3_001.jpg GRAPHIC 2088
  Complete submission text file 0001493152-21-001200.txt   9865254
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-252181 | Film No.: 21533121
SIC: 2835 In Vitro & In Vivo Diagnostic Substances